Metabolic associations of reduced proliferation and oxidative stress in advanced breast cancer

L Jerby, L Wolf, C Denkert, GY Stein, M Hilvo, M Oresic… - Cancer research, 2012 - AACR
Aberrant metabolism is a hallmark of cancer, but whole metabolomic flux measurements
remain scarce. To bridge this gap, we developed a novel metabolic phenotypic analysis …

[HTML][HTML] Impact of 27-hydroxylase (CYP27A1) and 27-hydroxycholesterol in breast cancer

S Kimbung, C Chang, PO Bendahl… - Endocrine-related …, 2017 - erc.bioscientifica.com
The impact of systemic 27-hydroxycholesterol (27HC) and intratumoral CYP27A1
expression on pathobiology and clinical response to statins in breast cancer needs …

Targeting fuel pocket of cancer cell metabolism: A focus on glutaminolysis

S Sharma, N Agnihotri, S Kumar - Biochemical pharmacology, 2022 - Elsevier
Advances in cell metabolism over the past few decades have demonstrated glutamine as an
essential nutrient for cancer cell survival and proliferation. Glutamine offers a remarkable …

Lactate dehydrogenase B: a metabolic marker of response to neoadjuvant chemotherapy in breast cancer

JB Dennison, JR Molina, S Mitra… - Clinical Cancer …, 2013 - AACR
Purpose: Although breast cancers are known to be molecularly heterogeneous, their
metabolic phenotype is less well-understood and may predict response to chemotherapy …

Ginsenoside CK induces apoptosis in triple-negative breast cancer cells by targeting glutamine metabolism

B Zhang, R Fu, Z Duan, S Shen, C Zhu, D Fan - Biochemical Pharmacology, 2022 - Elsevier
Breast cancer (BC) has replaced lung cancer as the most common cancer worldwide.
Ginsenoside CK (CK) can effectively inhibit triple-negative breast cancer (TNBC), the …

[HTML][HTML] A metabolism toolbox for CAR T therapy

X Xu, JNR Gnanaprakasam, J Sherman… - Frontiers in oncology, 2019 - frontiersin.org
The adoptive transfer of T cells expressing chimeric antigen receptors (CARs) through
genetic engineering is one of the most promising new therapies for treating cancer patients …

A phase I dose-escalation and expansion study of telaglenastat in patients with advanced or metastatic solid tumors

JJ Harding, M Telli, P Munster, MH Voss, JR Infante… - Clinical cancer …, 2021 - AACR
Purpose: Glutamine is a critical fuel for solid tumors. Interference with glutamine metabolism
is deleterious to neoplasia in preclinical models. A phase I study of the oral, first-in-class …

[HTML][HTML] Amino acid metabolism reprogramming: shedding new light on T cell anti-tumor immunity

Y Zheng, Y Yao, T Ge, S Ge, R Jia, X Song… - Journal of Experimental …, 2023 - Springer
Metabolic reprogramming of amino acids has been increasingly recognized to initiate and
fuel tumorigenesis and survival. Therefore, there is emerging interest in the application of …

[HTML][HTML] Metabostemness: a new cancer hallmark

JA Menendez, T Alarcón - Frontiers in oncology, 2014 - frontiersin.org
The acquisition of and departure from stemness in cancer tissues might not only be
hardwired by genetic controllers, but also by the pivotal regulatory role of the cellular …

[HTML][HTML] Targeting mitochondria with ClpP agonists as a novel therapeutic opportunity in breast cancer

R Wedam, YE Greer, DJ Wisniewski, S Weltz, M Kundu… - Cancers, 2023 - mdpi.com
Simple Summary Mitochondria, often called “the powerhouse of the cell”, generate most of
the energy required for all cellular processes. Mitochondria also provide a platform for …